PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Surgery, University of Utah Health, Salt Lake City, Utah, USA joseph.tonna@hsc.utah.edu.\', \'CellReGen, University of Utah Health, Salt Lake City, Utah, USA.\', \'Department of Medicine, University of Utah Health, Salt Lake City, Utah, USA.\', \'Department of Surgery, University of Utah Health, Salt Lake City, Utah, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1136/bmjopen-2020-045162
?:hasPublicationType
?:journal
  • BMJ open
is ?:pmid of
?:pmid
?:pmid
  • 33574155
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.372
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Safety and feasibility of using acellular sterile filtered amniotic fluid as a treatment for patients with COVID-19: protocol for a randomised, double-blinded, placebo-controlled clinical trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33574155>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33574155>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all